Mind Medicine (MindMed) Inc. (MNMD)

Mind Medicine (MindMed) Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-77.63	-108.68	-95.73	-56.8	-93.04	-33.94
Depreciation & Amortization	-0.5	0.03	-0.04	-0.02	0.02	-
Other Amortization	1.23	1.23	3.3	4.7	2.6	-
Stock-Based Compensation	16.61	17.67	15.49	13.71	42.72	7.41
Other Operating Activities	-26.53	13.97	6.33	-7.95	-	0.87
Change in Accounts Payable	-3.38	-2.13	2.03	-2.06	1.28	0.54
Change in Other Net Operating Assets	-1.75	-1.22	4.26	-1.73	1.76	1.52
Operating Cash Flow	-91.95	-79.13	-64.37	-50.14	-45.82	-23.6
Cash Acquisitions	-	-	-	-	-0.3	-
Investing Cash Flow	-162.46	-	-	-	-0.3	-
Long-Term Debt Issued	-	10	15	-	-	-
Net Debt Issued (Repaid)	10	10	15	-	-	-
Issuance of Common Stock	82.82	259.97	7.69	43.21	98.82	97.1
Repurchase of Common Stock	-	-0.05	-	-0.41	-	-
Other Financing Activities	-7.87	-16.72	-0.84	16.25	-	-0.4
Financing Cash Flow	84.95	253.2	21.85	59.05	98.82	96.7
Foreign Exchange Rate Adjustments	-0.02	-0.03	0.08	-0.31	0.74	0.28
Net Cash Flow	-169.48	174.04	-42.44	8.6	53.45	73.39
Cash Interest Paid	2.39	2.22	0.53	-	-	-
Levered Free Cash Flow	-96.27	-44.56	-26.39	-15.82	-8.21	-13.68
Unlevered Free Cash Flow	-95.47	-43.85	-25.91	-15.82	-7.99	-13.58
Change in Net Working Capital	40.91	-2.89	-14.1	-7.25	-5.15	0.34

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q